AXNX
Axonics Modulation Technologies Inc
NASDAQ: AXNX · HEALTHCARE · MEDICAL DEVICES
$0.43
-12.47% today
Updated 2026-10-20
Market cap
$3.63B
P/E ratio
—
P/S ratio
8.40x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$0 – $0
Volume
0.5M
Axonics Modulation Technologies Inc (AXNX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.43
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.2B | $0.3B | $0.4B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -1.31%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.